Thomas Horn

483 total citations
19 papers, 365 citations indexed

About

Thomas Horn is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Thomas Horn has authored 19 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Thomas Horn's work include Cancer-related Molecular Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Genetic factors in colorectal cancer (2 papers). Thomas Horn is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Genetic factors in colorectal cancer (2 papers). Thomas Horn collaborates with scholars based in United States, Germany and Denmark. Thomas Horn's co-authors include Ronald A. Lubet, David L. McCormick, William D. Johnson, Vernon E. Steele, Jonathan Phillips, Lisbeth N. Pedersen, Estrid Høgdall, Anne Roslind, F Burcharth and Julia S. Johansen and has published in prestigious journals such as Cancer Cell, Cancer Research and Science Translational Medicine.

In The Last Decade

Thomas Horn

18 papers receiving 352 citations

Peers

Thomas Horn
Peifen Fu China
Thomas Horn
Citations per year, relative to Thomas Horn Thomas Horn (= 1×) peers Peifen Fu

Countries citing papers authored by Thomas Horn

Since Specialization
Citations

This map shows the geographic impact of Thomas Horn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Horn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Horn more than expected).

Fields of papers citing papers by Thomas Horn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Horn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Horn. The network helps show where Thomas Horn may publish in the future.

Co-authorship network of co-authors of Thomas Horn

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Horn. A scholar is included among the top collaborators of Thomas Horn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Horn. Thomas Horn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tanne, Antoine, Simarjot Pabla, Sudesh Pawaria, et al.. (2020). Abstract 922: Expanding the therapeutic potential of anti-PD-1 and anti-CTLA-4 therapy with innovative Fc engineering and rationale combinations for the treatment of solid tumors. Cancer Research. 80(16_Supplement). 922–922. 1 indexed citations
2.
Tastanova, Aizhan, Marc Folcher, Marius Müller, et al.. (2018). Synthetic biology-based cellular biomedical tattoo for detection of hypercalcemia associated with cancer. Science Translational Medicine. 10(437). 42 indexed citations
3.
Waight, Jeremy D., Dhan Chand, Thomas Horn, et al.. (2018). Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens. Cancer Cell. 33(6). 1033–1047.e5. 64 indexed citations
4.
Kim, Sunkyu, Ralph Tiedt, Alice Loo, et al.. (2018). The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models. Oncotarget. 9(81). 35226–35240. 58 indexed citations
5.
Tiedt, Ralph, Scott Delach, Thomas Horn, et al.. (2017). Abstract 2346: Preclinical selectivity profile of the CDK4/6 inhibitor ribociclib (LEE011) compared with that of palbociclib and abemaciclib. Cancer Research. 77(13_Supplement). 2346–2346. 1 indexed citations
6.
Erdmann, Gerrit, Patrick Horn, Christian Volz, et al.. (2015). Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening. Genome Medicine. 7(1). 46–46. 4 indexed citations
7.
Horn, Thomas, et al.. (2013). Functional characterization of genetic enzyme variations in human lipoxygenases. Redox Biology. 1(1). 566–577. 27 indexed citations
8.
Horn, Thomas, et al.. (2013). Optimized ASIC/FPGA design flow for energy efficient network nodes. Bell Labs Technical Journal. 18(3). 195–209. 2 indexed citations
9.
Schultz, Nicolai Aagaard, Anne Roslind, Ib Jarle Christensen, et al.. (2012). Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas. Pancreas. 41(5). 759–766. 61 indexed citations
10.
McCormick, David L., Thomas Horn, William D. Johnson, Ronald A. Lubet, & Vernon E. Steele. (2012). Abstract B110: Chemoprevention of rat oral carcinogenesis by licofelone, a dual cyclooxygenase/lipoxygenase inhibitor. Cancer Prevention Research. 5(11_Supplement). B110–B110. 1 indexed citations
11.
Maurer, Tobias, Juan Antonio Aguilar‐Pimentel, Mark Thalgott, et al.. (2011). Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses. Urologic Oncology Seminars and Original Investigations. 31(7). 1395–1401. 10 indexed citations
12.
Horn, Thomas, et al.. (2011). Progress in Biological Threat Agent Vaccine Development. International Journal of Toxicology. 30(2). 143–152. 18 indexed citations
13.
McCormick, David L., Jonathan Phillips, Thomas Horn, et al.. (2010). Overexpression of Cyclooxygenase-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Nonselective COX Inhibitors. Cancer Prevention Research. 3(1). 73–81. 39 indexed citations
14.
Kamper, Anne‐Lise, et al.. (2006). [A severe case of interstitial nephritis caused by sodium valproate].. PubMed. 168(43). 3729–30.
15.
Kop, Christian, et al.. (2005). Tool Supported Extraction of Behavior Models.. 114–123. 3 indexed citations
16.
Fansa, Hisham, Gerburg Keilhoff, Thomas Horn, et al.. (2000). Stimulation of Schwann cell proliferation and axonal regeneration by FK 506. Restorative Neurology and Neuroscience. 16(2). 77–86. 24 indexed citations
17.
Svendsen, Lars Bo, Jørgen Thorup, Jørgen K. Larsen, Steffen Bülow, & Thomas Horn. (1990). Correlation between in vitro tetraploidy in skin fibroblasts and development of sporadic colorectal carcinomas. Cancer Genetics and Cytogenetics. 50(1). 139–148. 1 indexed citations
18.
Svendsen, Lars Bo, J. O. Søndergaard, J. Hegnhøj, et al.. (1987). In Vitro Tetraploidy in Patients with Ulcerative Colitis. Scandinavian Journal of Gastroenterology. 22(5). 601–605. 6 indexed citations
19.
Thase, Michael E., David A. Brent, John F. Neil, & Thomas Horn. (1985). Evaluation of depression in a general hospital: Utility and limitations of the dexamethasone suppression test. General Hospital Psychiatry. 7(1). 43–48. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026